Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: aleve / erythromycin base / simvastatin / boniva attending: chief complaint: hemoptysis major surgical or invasive procedure: flexible bronchoscopy x 2 rigid bronchoscopy with argon cauterization endotracheal intubation x2 history of present illness: 64yof w/ recent large b cell lymphoma in l suprahilar region diagnosed in s/p 6 cycles , w/ episodes of pe in and more recently in now on coumadin, p/w hemoptysis. pt began having scant hemoptysis on , but then on evening of had 10 episodes where she coughed up "quarter-sized" bloodclots. she then presented to , where she underwent cta, showing l hilar mass anterior to l main pulmonary artery 4cm in size occluding the lul main bronchus. given location and impingement on upper lobe bronchus, patient had bronchoscopy. there was initally concern for erosion into the pa, but our ip doctors here are concerned about the l upper lobe bronchial artery eroding and requested transfer here. of note, before transfer had received ctx x1 w/ bronchoscopy. . in the icu, patient c/o some subjective sob, which she states has been present since the bronchoscopy. denies further episodes of hemoptysis. denies fatigue/weakness. does endorse some wheezing, better than it has been in the past. denies fevers/chills. no cp, no abd pain/n/v. . also of note, patient is being treated for uti w/ macrodantin, started on for complaints of dysuria. she had been treated with a three day course 3 weeks prior, and stated her symptoms never got better, so it was decided to give her another extended course. no ua/culture was sent. no current urinary symptoms. past medical history: - coronary artery disease with history of myocardial infarction in , s/p 3 stents w/ last one in - osteoarthritis. - polymyalgia rheumatica - hypertension. - steroid-induced hyperglycemia. - status post bilateral oophorectomy for ovarian cyst (). - status post bilateral cataract surgeries - status post cholecystectomy. - status post r hip replacement in . post-op, the patient developed bilateral pulmonary emboli, ivc placed - she underwent a left hip replacement in . - gerd. - obesity. - depression. - "clot" involving left kidney. - hypercholesterolemia - pe in , lovenox-->coumadin bridge social history: - married - lives in with her husband, 2 of her daughters and a son who has special needs - 6 children in total and 3 grandchildren - does not work outside the home - former smoker for 40 years, quit 3 years ago - rare alcohol - denies use of illicit drugs. family history: - father died of unknown malignancy - mother died from complications secondary to hip surgery physical exam: gen: nad, aox3 heent: ncat, mmm, no oropharyngeal lesions neck: no cervical lymphadenopathy cardiac: rrr, no m/r/g, nl s1s2 lungs: ctab abd: soft, nt, nd + bs ext: no c/c/e pertinent results: pathology from bronchial washings left upper lobe, bronchial washings, cell block: - atypical. - rare atypical poorly-preserved epithelial cells, cannot exclude involvement by non-small cell lung carcinoma. immunohistochemical stains could not be interpreted due to scant tumor cells. cxr increase in density of large left hilar mass. as the patient is experiencing hemoptysis and the mass was associated with obstruction of the left upper lobe bronchus on prior pet ct of , consider bronchoscopy for further evaluation if not already performed. renal u/s findings: the right kidney measures 12.2 cm in its long axis and shows no masses, stones or hydronephrosis. the left kidney measures 10.6 cm in its long axis. off the inferior pole of the left kidney is an exophytic anechoic structure that measures 4.5 x 4.7 x 4.0 cm and shows through transmission and is most consistent with a cyst. it exhibits no abnormal vascularity. transverse and sagittal views of the bladder show it to be collapsed as the patient had recently voided. impression: left lower renal pole simple cyst. brief hospital course: 64yof w/ recent large b cell lymphoma in l suprahilar region diagnosed in s/p 6 cycles , w/ episodes of pe in and more recently in now on coumadin, p/w hemoptysis. micu course: patient was transferred from for further management of hemoptysis in the setting of a bleeding vessel from her tumor. here, interventional pulmonary was consulted and performed a flexible bronchoscopy which showed a fungating mass in the left upper lobe with a bleeding vessel. patient was taken for rigid bronchoscopy in or for debulking of tumor and argon cauterization. after the or, patient was brought back to the icu intubated because of paralytic received in or. patient was extubated in icu when she was responding to commands. however upon extubation, patient became extremely tachypneic and cyanotic, requiring reintubation. it was unclear why patient had acute respiratory distress but may have been flash pulmonary edema v. bronchospasm v. obstruction from tumor. patient was diuresed and transferred to icu for xrt prior to extubation. of note patient was started on macrodantin as outpatient for uti however urine cultures were negative so this was dc'ed. also of note, patient has h/o pe for which she is coumadin. prior to the bronchoscopy, inr was reversed with ffp. anticoagulation was not restarted given h/o hemoptysis. in , pt was extubated without complications and maintained o2 sat in mid-high 90s on 2l of nc. was transferred to the floor for further managment while receiving xrt. pathology preliminary report received after day one of xrt to chest, bronchial washings were not suggestive of lymphoid cells. xrt was held until final path report which showed atypical cells, cannot r/o nonsmall cell lung cancer, but it was recommended that more tissue be obtained to make a diagnosis. bronchoscopy is scheduled for in order to obtain more tissue and until then, radiation treatments are on hold. hemoptysis did not continue after extubation and transfer to bmt floor and sats improved, pt only required 2l nc of o2 at night (which she is on at home) at time of discharged and stated she was breathing better. coumadin and aspirin were held during her course on the bmt floor considering her presentation with hemoptysis and she was advised to continue not taking these medications until a diagnosis and treatment plan have been determined. her home blood pressure meds and other cardiac medications were continued, as well as her home meds for her copd. medications on admission: albuterol sulfate 90 mcg hfa aerosol inhaler q4-6h fluticasone-salmeterol - 100 mcg-50 mcg 1 puff furosemide 40mg daily glipizide - 2.5 mg daily levothyroxine - 175 mcg daily lorazepam - 1 mg prn qhs losartan - 50mg daily metoprolol tartrate - 50 mg in am, 25mg in pm nitrofurantoin (macrocryst25%) - 100 mg paroxetine hcl - 20 mg daily potassium chloride - 20 meq tab sust.rel. daily pravastatin - 20 mg daily tiotropium bromide - 18 mcg daily warfarin - 7.5 mg daily acetaminophen - 1250mg daily aspirin 81mg daily b.ani-l.aci-l.-l.plan-l.cas - daily calcium and vitamin d - (otc) folic acid - 0.4 mg daily multivitamin - daily discharge medications: 1. albuterol sulfate 90 mcg/actuation hfa aerosol inhaler sig: two (2) puff inhalation every 4-6 hours as needed for shortness of breath or wheezing. 2. fluticasone-salmeterol 100-50 mcg/dose disk with device sig: one (1) puff inhalation twice a day. 3. lasix 40 mg tablet sig: one (1) tablet po once a day. 4. glipizide 2.5 mg tablet extended rel 24 hr sig: one (1) tablet extended rel 24 hr po once a day. 5. levothyroxine 175 mcg tablet sig: one (1) tablet po once a day. tablet(s) 6. lorazepam 1 mg tablet sig: one (1) tablet po at bedtime as needed for insomnia. 7. losartan 50 mg tablet sig: one (1) tablet po hs (at bedtime). 8. metoprolol tartrate 50 mg tablet sig: one (1) tablet po qam (once a day (in the morning)). 9. metoprolol tartrate 25 mg tablet sig: one (1) tablet po qhs (once a day (at bedtime)). 10. paroxetine hcl 20 mg tablet sig: one (1) tablet po daily (daily). 11. pravastatin 20 mg tablet sig: one (1) tablet po daily (daily). 12. calcium carbonate 200 mg (500 mg) tablet, chewable sig: one (1) tablet, chewable po twice a day. 13. spiriva with handihaler 18 mcg capsule, w/inhalation device sig: one (1) inhalation once a day. 14. cholecalciferol (vitamin d3) 400 unit tablet sig: two (2) tablet po twice a day. 15. folic acid 1 mg tablet sig: one (1) tablet po once a day. 16. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po once a day. 17. acetaminophen 650 mg tablet sig: 1-2 tablets po once a day as needed for pain. tablet(s) discharge disposition: home discharge diagnosis: lung lesion, copd, heart failure discharge condition: mental status: clear and coherent. level of consciousness: alert and interactive. activity status: ambulatory - independent. discharge instructions: you were seen in the hospital for coughing up blood (also known as hemoptysis). this was most likely caused by a lesion found in your left lung by bronchoscopy, which the interventional pulmonologists coagulated during the bronchoscopy procedure. since there was not enough tissue to diagnose what this lung mass is, on friday you are scheduled for another bronchoscopy to get more tissue to better diagnose and treat the lung mass. for your heart failure, weigh yourself every morning, md if weight goes up more than 3 lbs. stop taking coumadin and aspirin until we have a better diagnosis and your radiation treatment is completed because of the risk of a bleed, no changes in your other medications. followup instructions: bronchoscopy on friday at 7:30 am md procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube fiber-optic bronchoscopy other lavage of bronchus and trachea control of hemorrhage, not otherwise specified other radiotherapeutic procedure endoscopic excision or destruction of lesion or tissue of bronchus diagnoses: coronary atherosclerosis of native coronary artery polymyalgia rheumatica esophageal reflux congestive heart failure, unspecified unspecified essential hypertension adrenal cortical steroids causing adverse effects in therapeutic use acute on chronic diastolic heart failure personal history of tobacco use depressive disorder, not elsewhere classified acute respiratory failure old myocardial infarction long-term (current) use of anticoagulants osteoarthrosis, unspecified whether generalized or localized, site unspecified other diseases of lung, not elsewhere classified personal history of venous thrombosis and embolism obesity, unspecified other hemoptysis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified other malignant lymphomas, intrathoracic lymph nodes 

Answer: The patient is high likely exposed to